128 related articles for article (PubMed ID: 18281774)
1. [Two advanced/recurrent breast cancer cases effectively treated by trastuzumab/capecitabine combination therapy].
Inoue S; Inoue M; Takahashi H; Inoue A; Kunitomo K; Fujii H
Gan To Kagaku Ryoho; 2008 Feb; 35(2):319-22. PubMed ID: 18281774
[TBL] [Abstract][Full Text] [Related]
2. [A patient with axillary node metastasis from breast cancer who responded to trastuzumab/capecitabine combination therapy].
Tokugawa T; Kobayashi A; Matsuyama T; Imai S; Koyama H
Gan To Kagaku Ryoho; 2009 Mar; 36(3):467-9. PubMed ID: 19295273
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase II trial of first-line trastuzumab plus docetaxel and capecitabine compared with trastuzumab plus docetaxel in HER2-positive metastatic breast cancer.
Wardley AM; Pivot X; Morales-Vasquez F; Zetina LM; de Fátima Dias Gaui M; Reyes DO; Jassem J; Barton C; Button P; Hersberger V; Torres AA
J Clin Oncol; 2010 Feb; 28(6):976-83. PubMed ID: 20038734
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial.
Yamamoto D; Iwase S; Kitamura K; Odagiri H; Yamamoto C; Nagumo Y
Cancer Chemother Pharmacol; 2008 Mar; 61(3):509-14. PubMed ID: 17516068
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes.
Schaller G; Fuchs I; Gonsch T; Weber J; Kleine-Tebbe A; Klare P; Hindenburg HJ; Lakner V; Hinke A; Bangemann N
J Clin Oncol; 2007 Aug; 25(22):3246-50. PubMed ID: 17577021
[TBL] [Abstract][Full Text] [Related]
6. [A case of metastatic breast cancer with liver metastasis effectively treated with capecitabine and vinorelbine].
Inari H; Chiba A; Inaba M; Ino H; Fukahori M; Yoshida A
Gan To Kagaku Ryoho; 2009 Feb; 36(2):333-5. PubMed ID: 19223759
[TBL] [Abstract][Full Text] [Related]
7. Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement.
Giotta F; Latorre A; Cramarossa A; Simone G; Florio C; Oliva S; Lorusso V
Tumori; 2013; 99(6):278e-81e. PubMed ID: 24503803
[TBL] [Abstract][Full Text] [Related]
8. [A case of paclitaxel and trastuzumab-resistant recurrent breast cancer with liver metastasis responding to S-1].
Nomura T; Sonoo H; Miyake A; Souda M; Yamamoto Y; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Kurebayashi J
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1607-10. PubMed ID: 18799922
[TBL] [Abstract][Full Text] [Related]
9. [A case of triple negative recurrent breast cancer successfully treated with capecitabine+docetaxel combination chemotherapy].
Hachisuka Y; Kamei Y; Umeoka T; Kimura M; Uomoto M; Hatano H; Johira H; Yunoki S; Kawata N; Watanabe R; Ohmori K; Miyata N
Gan To Kagaku Ryoho; 2008 Mar; 35(3):475-8. PubMed ID: 18347398
[TBL] [Abstract][Full Text] [Related]
10. [An effective case of liver metastasis of breast cancer treated with capecitabine + docetaxel combination therapy using vitamin B6].
Umeda T; Abe H; Cho H; Shimizu T; Mori T; Kubota Y; Kawai Y; Tanaka M; Kurumi Y; Tani T
Gan To Kagaku Ryoho; 2010 Apr; 37(4):687-9. PubMed ID: 20414027
[TBL] [Abstract][Full Text] [Related]
11. Complete remission of recurrent breast cancer with multiple liver metastases after oral capecitabine and injected trastuzumab.
Morohashi S; Odagiri H; Morohashi H; Kimura Y; Sasaki M
Breast Cancer; 2007; 14(3):297-301. PubMed ID: 17690508
[TBL] [Abstract][Full Text] [Related]
12. Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function.
Schüll B; Scheithauer W; Kornek GV
Onkologie; 2003 Dec; 26(6):578-80. PubMed ID: 14709934
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer.
Chan A; Conte PF; Petruzelka L; Tubiana-Mathieu N; Ganju V; Llombart A; Espie M; Majois F; Gil MG; Vaissiere N; Villanova G
Anticancer Res; 2013 Jun; 33(6):2657-64. PubMed ID: 23749924
[TBL] [Abstract][Full Text] [Related]
14. [Case report of advanced breast cancer responding to capecitabine and trastuzumab combination therapy].
Yoshidome K; Imabun S; Nakahara M; Hiraoka K; Yamagami Y; Tsujimoto M; Nakao K
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1453-6. PubMed ID: 17033236
[TBL] [Abstract][Full Text] [Related]
15. [Successful treatment of trastuzumab-resistant HER2-positive breast cancer with extensive liver metastases using the combination of trastuzumab and capecitabine - a case report].
Shigekawa T; Takeuchi H; Misumi M; Nakamiya N; Sugiyama M; Sugitani I; Fujiuchi N; Osaki A; Saeki T
Gan To Kagaku Ryoho; 2013 Feb; 40(2):225-7. PubMed ID: 23411960
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
Gajria D; Gonzalez J; Feigin K; Patil S; Chen C; Theodoulou M; Drullinsky P; D'Andrea G; Lake D; Norton L; Hudis CA; Traina TA
Breast Cancer Res Treat; 2012 Jan; 131(1):111-6. PubMed ID: 21898114
[TBL] [Abstract][Full Text] [Related]
17. Lapatinib plus capecitabine in breast cancer.
Sonpavde G
N Engl J Med; 2007 Apr; 356(14):1471; author reply 1471-2. PubMed ID: 17409332
[No Abstract] [Full Text] [Related]
18. Lapatinib in metastatic breast cancer.
Frenel JS; Bourbouloux E; Berton-Rigaud D; Sadot-Lebouvier S; Zanetti A; Campone M
Womens Health (Lond); 2009 Nov; 5(6):603-12. PubMed ID: 19863462
[TBL] [Abstract][Full Text] [Related]
19. CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.
Pivot X; Manikhas A; Żurawski B; Chmielowska E; Karaszewska B; Allerton R; Chan S; Fabi A; Bidoli P; Gori S; Ciruelos E; Dank M; Hornyak L; Margolin S; Nusch A; Parikh R; Nagi F; DeSilvio M; Santillana S; Swaby RF; Semiglazov V
J Clin Oncol; 2015 May; 33(14):1564-73. PubMed ID: 25605838
[TBL] [Abstract][Full Text] [Related]
20. [Combination therapy herceptin+xeloda].
Schaller G
Onkologie; 2002 Dec; 25 Suppl 5():17-8; discussion 19. PubMed ID: 23573615
[No Abstract] [Full Text] [Related]
[Next] [New Search]